Monterey Bio Acquisition Corporation (MTRY)
Monterey Bio Acquisition Corporation operates in the Shell Companies industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $11.14, down 0.27% on the session, giving a market capitalisation of $48.3M. On trailing twelve-month figures it carries a trailing P/E of -25.32, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021. It is headquartered in New York, New York.
Monterey Bio Acquisition Corporation is most often compared with the following Financial Services names: